SCHEMBL11908136

SCHEMBL11908136

Nc1nc(OCCOC(F)F)c(C(=O)N[C@H]2CC[C@H](C(F)(F)F)CC2)cc1[N+](=O)[O-]

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
POLB P06746 1/20 0.35
CNR2 P34972 2/20 0.34
MLNR O43193 1/20 0.34
ADRB2 P07550 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
CHRM3 P20309 1/20 0.34
SLC6A2 P23975 1/20 0.34
HTR2A P28223 1/20 0.34
SLC6A4 P31645 1/20 0.34
HRH1 P35367 1/20 0.34
DRD3 P35462 1/20 0.34
OPRK1 P41145 1/20 0.34
HTR2B P41595 1/20 0.34
CHRNA4 P43681 1/20 0.34
HTR3A P46098 1/20 0.34
SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11908138 1.00 ALDH1A1 (0.37) ALDH1A1POLBCNR2MLNRADRB2
SCHEMBL11909206 0.90 ALDH1A1 (0.39) ALDH1A1POLBCNR2MLNRADRB2
SCHEMBL11909205 0.90 ALDH1A1 (0.39) ALDH1A1POLBCNR2MLNRADRB2
SCHEMBL11907925 0.89 ALDH1A1 (0.39) ALDH1A1POLBCNR2MLNRADRB2
SCHEMBL673728 0.89 ALDH1A1 (0.39) ALDH1A1POLBCNR2MLNRADRB2
SCHEMBL11907927 0.89 ALDH1A1 (0.39) ALDH1A1POLBCNR2MLNRADRB2
SCHEMBL11908168 0.89 ALDH1A1 (0.39) ALDH1A1POLBCNR2MLNRADRB2
SCHEMBL11908368 0.89 PTGES (0.41) ALDH1A1POLBCNR2MLNRADRB2
SCHEMBL11908364 0.89 PTGES (0.41) ALDH1A1POLBCNR2MLNRADRB2
SCHEMBL11980765 0.89 CNR2 (0.39) ALDH1A1POLBCNR2MLNRADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8586604-B2 Inhibitors of the microsomal prostaglandin E2 synthase-1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-11-19 US disclosed
US-20120208839-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120208839-A1 NEW COMPOUNDS PTGER1, PTGS1, PTGES ALDH1A1 173/4885POLB 2198/4885CNR2 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.